Jump to content

Drilldown: Medicines

Choose a table:


Medicines > classes : Classic Psychedelic or Stimulant or [[:Category:Sympathomimetics|Sympathomimetic]]

Use the filters below to narrow your results.

generic:
brand:
None (111) · Adipex-P, Lomaira (low-dose); with topiramate as Qsymia (1) · Benzedrex (1) · Delysid (historical, Sandoz, withdrawn 1965) (1) · EpiPen, EpiPen Jr, Auvi-Q, Adrenaclick, Symjepi; many generic (1)
classes: (Click arrow to add another value)
mechanism:
5-HT2A agonist (26) · Monoamine releasing agent (8) · Dopamine/norepinephrine reuptake inhibitor (5) · Potent 5-HT2A agonist (5) · LSD analogue; 5-HT2A agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · Cathinone analogue; monoamine reuptake inhibitor (2) · Contains LSA (2) · Contains mescaline (2) · Dopamine and norepinephrine reuptake inhibitor (2) · Norepinephrine–dopamine reuptake inhibitor (2)
uses:
None (113) · '"`UNIQ--vote-00000E4C-QINU`"', '"`UNIQ--vote-00000E4D-QINU`"', '"`UNIQ--vote-00000E4E-QINU`"', '"`UNIQ--vote-00000E4F-QINU`"', '"`UNIQ--vote-00000E50-QINU`"', '"`UNIQ--vote-00000E51-QINU`"' (1) · '"`UNIQ--vote-0000129E-QINU`"' (1)
starting dose:
None (113) · 15-37.5 mg PO once daily before breakfast or 1-2 hours after; Lomaira 8 mg TID (1) · Anaphylaxis IM 0.3-0.5 mg (adult) into lateral thigh, repeat q5-15 minutes prn; pediatric 0.01 mg/kg IM (max 0.3 mg, max 0.5 mg in adolescents); cardiac arrest 1 mg IV/IO q3-5 minutes; severe asthma neb 0.1 mg/kg up to 5 mg; never IV bolus for anaphylaxis outside critical care (1)
preparations:
None (113) · 15, 30, 37.5 mg capsules/tablets; 8 mg Lomaira (1) · Auto-injectors 0.15 mg (Jr/pediatric), 0.3 mg (adult); 1 mg/mL (1:1,000) ampules for IM/SC use; 0.1 mg/mL (1:10,000) for IV use; 2.25% racemic nebulizer (1)
fda max:
None (113) · 37.5 mg/d (1) · Indication-specific; ACLS no fixed cumulative ceiling (1)
routes:
None (112) · endotracheal (legacy ACLS (1) · IM (1) · intracardiac (historical only) (1) · IV (1) · nebulized (1) · not preferred) (1) · Oral (2) · SC (less common) (1)
onset:
None (112) · 30–60 minutes (1) · Appetite suppression within hours; weight loss over weeks-months (1) · IM: 5-10 minutes; IV: seconds; nebulized: 5-10 minutes (1)
duration:
None (112) · 5-15 minutes (1) · 8–12 hours (1) · ~12-14 hours (1)
halflife:
None (112) · 3–5 hours (1) · ~2 minutes'"`UNIQ--ref-00000E52-QINU`"' (1) · ~25 hours'"`UNIQ--ref-0000129F-QINU`"' (1)
bioavailability:
None (112) · 70–90% (oral) (1) · High (oral)'"`UNIQ--ref-000012A0-QINU`"' (1) · IM/SC ~100%; oral negligible (extensive first-pass and gut metabolism — hence the no-oral route)'"`UNIQ--ref-00000E53-QINU`"' (1)
pregnancy:
None (112) · Contraindicated in pregnancy.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1) · Not established (1) · Used in life-threatening obstetric anaphylaxis without hesitation; benefits clearly outweigh.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)
legal:
None (113) · Schedule I (United States) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)

Showing below up to 115 results in range #1 to #115.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)


View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"